These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27201036)

  • 1. Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector.
    Tuna E; Tatar M; Ergin G; Senturk A; Atikeler K
    Value Health; 2014 Nov; 17(7):A415. PubMed ID: 27201036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals].
    Hammerman A; Greenberg D
    Harefuah; 2012 Jun; 151(6):364-7, 376. PubMed ID: 22991869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of two pharmaceutical risk-sharing agreements on pricing, promotion, and net health benefits.
    Zaric GS; Xie B
    Value Health; 2009; 12(5):838-45. PubMed ID: 19490563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement.
    Neumann PJ; Chambers JD; Simon F; Meckley LM
    Health Aff (Millwood); 2011 Dec; 30(12):2329-37. PubMed ID: 22147861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden.
    Ferrario A; Kanavos P
    Soc Sci Med; 2015 Jan; 124():39-47. PubMed ID: 25461860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk sharing agreements: what lessons from Italy?
    Garattini L; Casadei G
    Int J Technol Assess Health Care; 2011 Apr; 27(2):169-72. PubMed ID: 21429288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do cost-sharing and entry deregulation curb pharmaceutical innovation?
    Grossmann V
    J Health Econ; 2013 Sep; 32(5):881-94. PubMed ID: 23896384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk-sharing agreements: choice of study design and assessment criteria].
    Launois R; Ethgen O
    Ann Pharm Fr; 2013 Sep; 71(5):346-57. PubMed ID: 24075705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innovative agreements with the pharmaceutical industry: "pay for performance"].
    Badia X; Prior M
    Farm Hosp; 2010; 34(2):53-5. PubMed ID: 20207566
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-Sharing Agreements In Australia: Attitude Towards Risk-Sharing Arrangements With The Department Of Health For The Pbs-Listing Of Pharmaceuticals.
    Makino K; Tilden D; Kamei M; Shibata K
    Value Health; 2014 Nov; 17(7):A801. PubMed ID: 27203014
    [No Abstract]   [Full Text] [Related]  

  • 13. Knowledge sharing in the health scenario.
    Lluch-Ariet M; Brugués de la Torre A; Vallverdú F; Pegueroles-Vallés J
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S8. PubMed ID: 25471452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk-sharing scheme in Israel--Kuvan as an allegory].
    Abadi-Korek I; Shemer J
    Harefuah; 2012 Jun; 151(6):362-3, 377, 376. PubMed ID: 22991868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sharing medication agreements with patients.
    Crouch D
    Nurs Times; 2003 Sep 23-29; 99(38):34-6. PubMed ID: 14562433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sharing of biotechnology: contractual agreements as avant-garde].
    Noiville C
    Med Sci (Paris); 2005 Nov; 21(11):998-1001. PubMed ID: 16274654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The primary reasons behind data sharing, its wider benefits and how to cope with the realities of commercial data.
    Tellam RL; Rushton P; Schuerman P; Pala I; Anane D
    BMC Genomics; 2015 Sep; 16(1):626. PubMed ID: 26343138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life of Turkish type 2 diabetics in Germany and Turkey--a comparison between Hamburg and Istanbul.
    Kofahl C; Doğan M; Doğan G; Mnich E; von dem Knesebeck O
    Ethn Health; 2014; 19(6):617-30. PubMed ID: 24517236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.